Should anticoagulation be resumed after intracerebral hemorrhage?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21048052.
- Also identified by DOI 10.3949/ccjm.77a.10018 and PMC identifier PMC2677505.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation-associated ICH.